Company intelligence
Cepheid
About Cepheid
Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The company's GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform world-class PCR testing. Cepheid’s broad test portfolio spans respiratory infections, blood virology, women’s and sexual health, TB and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics. The company’s solutions deliver actionable results where they are needed most – from central laboratories and hospitals to near-patient settings. For more information, visit http://www.cepheid.com. Cepheid is proud to be a part of Danaher. Danaher’s science and technology leadership puts Cepheid’s solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers. Together with Danaher’s other businesses across Biotechnology, Diagnostics, and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.
Verified activity
Signals from Cepheid
11 published signals
Presence & Recognition
Cepheid hosted an Asian Pacific Society of Respirology (APSR) webinar on demand featuring Dr. Cristina Russo and Dr. Patrick Harris to explore the evolving respiratory landscape, optimizing diagnostic strategies, and achieving clinical and economic efficiencies across respiratory care settings.
Reported by Cepheid
Products & Services
Cepheid announced the VIP test launch for ResumeRuler, a tool that scores job alert matches and boosts ATS fit for job seekers.
Reported by Justin Wilson
Presence & Recognition
Cepheid and Cruinn Diagnostics co-hosted a free, in-person National User Day event for Northern Ireland NHS and Ireland HSE healthcare workers on Wednesday, 16th September 2026 at the Ashling Hotel in Stoneybatter, Dublin.
Reported by Cepheid
Products & Services
Cepheid offers Blood Virology, Women’s Health, and Sexual Health testing solutions for molecular diagnostics to support informed clinical decision-making.
Reported by Cepheid
Legal & Regulatory
Cepheid received WHO Emergency Use Listing for the Xpert Hemorrhagic Fever Panel supporting the Ebola Bundibugyo outbreak response with over 6,000 reported cases and over 3,000 deaths.
Reported by Estefi Alvarez, PhD
Legal & Regulatory
Cepheid has received Emergency Use Listing (EUL) from the World Health Organization for its Xpert Hemorrhagic Fever Panel to support efforts during the Ebola outbreak in the Democratic Republic of the Congo.
Reported by Cepheid
Legal & Regulatory
Cepheid and its global health partners received Emergency Use Listing from WHO for the Xpert Hemorrhagic Fever Panel to support the current Ebola outbreak response in the Democratic Republic of Congo.
Reported by Luben Li
Presence & Recognition
Cepheid spoke about Data Protection in the AI Era at the CISO Assembly in Austin on August-12, organized by Millennium Alliance
Reported by Prashanth Naidu
Partnerships
Cepheid and the Fleming Initiative came together to align on a comprehensive roadmap for clinical evidence generation, real-world data, and communications efforts supporting antimicrobial resistance and diagnostic excellence.
Reported by Cepheid
Research & Knowledge
Cepheid published a DOE model with an R² of 95% that fits experimental data well.
Reported by Brijesh P.
Presence & Recognition
Cepheid announced that the Finished Goods Release Lead-Time Reduction Team won the 2026 President's Kaizen Sustainment Award
Reported by Cepheid